Effects of Bariatric Surgery on Cardiac Ectopic Fat: Lesser Decrease in Epicardial Fat Compared to Visceral Fat Loss and No Change in Myocardial Triglyceride Content

Archive ouverte

Gaborit, B. | Jacquier, A. | Kober, F. | Abdesselam, I. | Cuisset, T. | Boullu-Ciocca, S. | Emungania, O. | Alessi, Marie-Christine | Clement, K. | Bernard, Monique | Dutour, A.

Edité par CCSD ; Elsevier -

Gaborit, Benedicte Jacquier, Alexis Kober, Frank Abdesselam, Ines Cuisset, Thomas Boullu-Ciocca, Sandrine Emungania, Olivier Alessi, Marie-Christine Clement, Karine Bernard, Monique Dutour, Anne Journal article Journal of the American College of Cardiology J Am Coll Cardiol. 2012 Oct 9;60(15):1381-1389. doi: 10.1016/j.jacc.2012.06.016. Epub 2012 Aug 29.. OBJECTIVES: This study investigated the effect of bariatric surgery (BS)-induced weight loss on cardiac ectopic fat using 3T magnetic resonance imaging in morbid obesity. BACKGROUND: Heart disease is one of the leading causes of mortality and morbidity in obese patients. Deposition of cardiac ectopic fat has been related to increased heart risk. Whether sustained weight loss can modulate epicardial fat or myocardial fat is unknown. METHODS: Twenty-three morbidly obese patients underwent (1)H-magnetic resonance spectroscopy to determine myocardial triglyceride content (MTGC), magnetic resonance imaging to assess epicardial fat volume (EFV), cardiac function, and computed tomography visceral abdominal fat (VAF) measurements at baseline and 6 months after BS. RESULTS: The BS reduced body mass index significantly, from 43.1 +/- 4.5 kg/m(2) to 32.3 +/- 4.0 kg/m(2), subcutaneous fat from 649 +/- 162 cm(2) to 442 +/- 127 cm(2), VAF from 190 +/- 83 cm(2) to 107 +/- 44 cm(2), and EFV from 137 +/- 37 ml to 98 +/- 25 ml (all p < 0.0001). There was no significant change in MTGC: 1.03 +/- 0.2% versus 1.1 +/- 0.2% (p = 0.85). A significant reduction in left ventricular mass (118 +/- 24 g vs. 101 +/- 18 g) and cardiac output (7.1 +/- 1.6 l/min vs. 5.4 +/- 1.0 l/min) was observed and was statistically associated with weight loss (p < 0.05). The loss in EFV was limited (-27 +/- 11%) compared to VAF diminution (-40 +/- 19%). The EFV variation was not correlated with percentage of body mass index or VAF loss (p = 0.007). The ratio of %EFV to %VAF loss decreased with sleep apnea syndrome (1.34 +/- 0.3 vs. 0.52 +/- 0.08, p < 0.05). CONCLUSIONS: Six-month BS modulates differently cardiac ectopic fat deposition, with a significant decrease in epicardial fat and no change in myocardial fat. Epicardial fat volume loss was limited in patients with sleep apnea. (Impact of Bariatric Surgery on Epicardial Adipose Tissue and on Myocardial Function; NCT01284816).

Consulter en ligne

Suggestions

Du même auteur

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

Archive ouverte | Gaborit, B. | CCSD

Gaborit, B Kober, F Jacquier, A Moro, P J Cuisset, T Boullu, S Dadoun, F Alessi, M-C Morange, P Clement, K Bernard, M Dutour, A Comparative Study Research Support, Non-U.S. Gov't England International journal of obesity (2005) Int...

Epicardial fat volume is associated with coronary microvascular response in healthy subjects: a pilot study

Archive ouverte | Gaborit, B. | CCSD

Gaborit, Benedicte Kober, Frank Jacquier, Alexis Moro, Pierre Julien Flavian, Antonin Quilici, Jacques Cuisset, Thomas Simeoni, Umberto Cozzone, Patrick Alessi, Marie-Christine Clement, Karine Bernard, Monique Dutour, Anne Researc...

Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss: Importance of diabetic status and modulation with bariatric surgery-induced weight loss

Archive ouverte | Gaborit, B. | CCSD

International audience. OBJECTIVES: Recent literature suggests that ectopic fat deposition in the pancreas may contribute to endocrine and exocrine organ dysfunction, such as type 2 diabetes (T2D), pancreatitis or p...

Chargement des enrichissements...